Sunil Karnawat Biography and Net Worth

Mr. Karnawat has over 25 years of experience in global commercialization of biopharmaceuticals and medical devices. He has launched products across multiple disease states, including ultra-rare bone and metabolic diseases, diabetes, obesity, and rheumatoid arthritis. Before joining the Company, Mr. Karnawat served as a Vice President at Cytokinetics and Ultragenyx. At Ultragenyx, he was responsible for leading key commercial functions in launching four ultra-rare disease products, including Crysvita with indications for X-linked Hypophosphatemia and Tumor-induced Osteomalacia. Before that, he led the Market Access teams at Myriad Genetics and Vivus Pharmaceuticals. At Novo Nordisk, Mr. Karnawat led Analytics and Commercial Operations teams to support the US launch of Victoza. He was a Field Sales Leader at LifeScan, a Johnson & Johnson franchise, for blood glucose monitors. Mr. Karnawat started his career at Deloitte Consulting. His education includes an MBA from the Wharton School of Business at the University of Pennsylvania, a Ph.D. and an M.S. in Engineering from North Dakota State University, and a B.E. in Civil Engineering from the College of Engineering in Pune, India.